NVAX
Novavax, Inc.
NasdaqGSUSDEQUITY
DELAYED
Last price
8.93
▲ 0.51 (6.06%)
MARKET · —
Price
Open
8.44
Prev close
8.42
Day high
9.20
Day low
8.44
Volume
10.44M
Market cap
—
P/E (TTM)
—
52W range
6.20 – 11.97
Trailing performance
Returnvs SPY
1W
+11.06%
+12.4%
1M
+14.18%
+10.4%
3M
-0.45%
-3.5%
6M
-2.83%
-13.9%
YTD
+33.04%
+20.7%
1Y
+2.29%
-17.7%
3Y
+25.39%
-48.8%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap—
Enterprise value—
Revenue (TTM)—
Gross profit—
EBITDA—
Net income—
EPS (TTM)—
Free cash flow—
Total cash—
Total debt—
Book value / share—
Shares outstanding—
Float—
Short % of float—
Dividend yield—
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA—
Gross margin—
Operating margin—
Profit margin—
Return on equity—
Return on assets—
Debt / equity—
Current ratio—
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
Consensus—
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders—
Held by institutions—
Institutions holding—
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
8.21
+8.72% from price
SMA 20
7.88
+13.48% from price
SMA 50
8.46
+5.65% from price
SMA 100
8.69
+2.79% from price
SMA 200
8.44
+5.97% from price
EMA 12
8.24
+8.38% from price
EMA 26
8.18
+9.16% from price
EMA 50
8.37
+6.69% from price
RSI (14)
63.2
Neutral
MACD (12,26,9)
0.06
Hist 0.16
ATR (14)
0.39
4.39% of price
Realised vol 30D
50.9%
Annualised
Bollinger upper
8.76
20, 2σ
Bollinger lower
6.99
20, 2σ
50 / 200 cross
Golden
8.46 vs 8.44
Trend bias
Above 200
+5.97%
Risk profile
Beta vs SPY
1.86
More volatile than market
Correlation to SPY
0.37
Loosely linked
Realised vol 30D
50.9%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-34.9%
Peak to trough
Max drawdown 5Y
-98.6%
Peak to trough
ATR 14
0.39
4.39% of price
Beta (reported)
—
5Y monthly, from filing
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Headlines
Stocks making big moves this week: Bally's, Adobe, Novavax, Semtech, and STAAR Surgical
StockStory · 9h ago
NVAX Stock Alert: Biotechs Hit Post-Pandemic High on mRNA Cancer Breakthrough
Barchart · 1d ago
3 Unprofitable Stocks Walking a Fine Line
StockStory · 1d ago
BioNTech Stock Surges 22% on Moderna Cancer Vaccine Win. Why the Gains Could Fade.
Barrons.com · 2d ago
Moderna’s Personalized Cancer Vaccine Proves Its mRNA Tech Works. A $3 Billion Market Awaits.
Barrons.com · 2d ago
Novavax (NVAX) Shares Skyrocket, What You Need To Know
StockStory · 3d ago
Is Sanofi (ENXTPA:SAN) Reasonable After A 10% Three Year Slide?
Simply Wall St. · 3d ago
Valneva Q2 Earnings Call Highlights
MarketBeat · 9d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.